166 related articles for article (PubMed ID: 37247067)
1. Hepatic Stellate Cell Targeting Using Peptide-Modified Biologicals.
Bansal R; Poelstra K
Methods Mol Biol; 2023; 2669():269-284. PubMed ID: 37247067
[TBL] [Abstract][Full Text] [Related]
2. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
[TBL] [Abstract][Full Text] [Related]
3. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
[TBL] [Abstract][Full Text] [Related]
4. A magnetic resonance imaging modality for non-invasively distinguishing progression of liver fibrosis by visualizing hepatic platelet-derived growth factor receptor-beta expression in mice.
Wu L; Huang XQ; Li N; Xie C; Rao SX; Chen SY; Li F
J Gastroenterol Hepatol; 2021 Dec; 36(12):3448-3456. PubMed ID: 34278598
[TBL] [Abstract][Full Text] [Related]
5. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells.
Li Q; Yan Z; Li F; Lu W; Wang J; Guo C
Nanotechnology; 2012 Jul; 23(26):265101. PubMed ID: 22700686
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo.
Bansal R; Prakash J; De Ruiter M; Poelstra K
J Control Release; 2014 Apr; 179():18-24. PubMed ID: 24491909
[TBL] [Abstract][Full Text] [Related]
7. Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo.
Bansal R; Prakash J; De Ruiter M; Poelstra K
PLoS One; 2014; 9(2):e89878. PubMed ID: 24587093
[TBL] [Abstract][Full Text] [Related]
8. RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats.
Chen SW; Zhang XR; Wang CZ; Chen WZ; Xie WF; Chen YX
Liver Int; 2008 Dec; 28(10):1446-57. PubMed ID: 18466260
[TBL] [Abstract][Full Text] [Related]
9. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats.
Chen SW; Chen YX; Zhang XR; Qian H; Chen WZ; Xie WF
Gene Ther; 2008 Nov; 15(21):1424-35. PubMed ID: 18509379
[TBL] [Abstract][Full Text] [Related]
11. Peptide-Based siRNA Nanocomplexes Targeting Hepatic Stellate Cells.
Lin CY; Mamani UF; Guo Y; Liu Y; Cheng K
Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979383
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
13. Disease-induced drug targeting using novel peptide-ligand albumins.
Meijer DK; Beljaars L; Molema G; Poelstra K
J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
[TBL] [Abstract][Full Text] [Related]
14. Highly Selective Targeting of Hepatic Stellate Cells for Liver Fibrosis Treatment Using a d-Enantiomeric Peptide Ligand of Fn14 Identified by Mirror-Image mRNA Display.
Huang L; Xie J; Bi Q; Li Z; Liu S; Shen Q; Li C
Mol Pharm; 2017 May; 14(5):1742-1753. PubMed ID: 28358987
[TBL] [Abstract][Full Text] [Related]
15. Targeted truncated TGF-β receptor type II delivery to fibrotic liver by PDGFβ receptor-binding peptide modification for improving the anti-fibrotic activity against hepatic fibrosis in vitro and in vivo.
Huang Z; Ding M; Dong Y; Ma M; Song X; Liu Y; Gao Z; Guan H; Chu Y; Feng H; Wang X; Liu H
Int J Biol Macromol; 2021 Oct; 188():941-949. PubMed ID: 34389395
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis.
Baghaei K; Mazhari S; Tokhanbigli S; Parsamanesh G; Alavifard H; Schaafsma D; Ghavami S
Drug Discov Today; 2022 Apr; 27(4):1044-1061. PubMed ID: 34952225
[TBL] [Abstract][Full Text] [Related]
17. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
[TBL] [Abstract][Full Text] [Related]
18. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
20. Gα
Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
